Donating to the Cancer Impact Booster

Are you interested in boosting our investment in cutting-edge cancer start-ups?

Impact booster

£7.4m

Seed Fund committed to date

£32.7m

co-investment secured to date

19

new investments to date

7

pending investments

Translating science into impact

Through advances in technology, we’re on the threshold of a golden age of scientific progress against cancer. Start-ups are one of the fastest ways of translating that progress into impact for patients.

But there’s a funding gap between cutting-edge academic cancer research and a start-up becoming ready for commercial investment. Too many potential treatments, devices and innovations are lost here.

We have an opportunity to deliver huge future impact for patients by supporting start-ups through this gap.  Which is why we committed £15m to a Seed Fund which accelerates high-potential, early-stage innovations into patient impact through seed funding, expert networks and business building support. Any financial returns generated are reinvested in the fund and into more cancer research.

Researcher wearing safety goggles and gloves

Support innovative cancer start-ups

With your support we could do so much more to grow the number and scale of our investments, and translate these innovations into real benefits for patients.

We're looking to double the impact of our Seed Fund commitment, through a total of £15m donations to our Cancer Impact Booster from visionary philanthropists who want to help us invest in the most innovative cancer start-ups. 

The Horizons Seed Fund represents an exciting opportunity for us to support the very best early-stage discovery research through to potentially life-changing benefits for patients, and we’re delighted to be supporting Cancer Research UK with this new venture

Nick and Annette Razey, inaugural donors to the fund – with our thanks for your important support

Speak to the Philanthropy team to find out more

Claire Moore

Claire Moore

Philanthropy Lead

[email protected]